1
Clinical Trials associated with Chimeric Natural Killer Receptor-Universal T Cells(Nanjing Children's Hospital)A Study to Evaluate the Safety, Preliminary Efficacy, Pharmacokinetics of CNK-UT Cells to Treat the Patients with Relapsed/refractory Neuroblastoma
This is a single arm, open-label, multi-center, pilot studies (Investigator Initiated Trial, IIT) to evaluate the safety, preliminary efficacy, pharmacokinetics of universal T-cells engineered with chimeric natural killer receptor (CNK-UT) to treat the patients with relapsed/refractory Neuroblastoma.
100 Clinical Results associated with Chimeric Natural Killer Receptor-Universal T Cells(Nanjing Children's Hospital)
100 Translational Medicine associated with Chimeric Natural Killer Receptor-Universal T Cells(Nanjing Children's Hospital)
100 Patents (Medical) associated with Chimeric Natural Killer Receptor-Universal T Cells(Nanjing Children's Hospital)
100 Deals associated with Chimeric Natural Killer Receptor-Universal T Cells(Nanjing Children's Hospital)